Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.22.2.2
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Segment Reporting Information [Line Items]        
Revenues $ 26,603,000 $ 20,991,621 $ 74,098,856 $ 58,758,383
Depreciation and amortization 2,011,768 1,662,255 5,341,420 4,275,140
Segment operating income (loss) 500,472 1,338,878 797,253 5,345,305
Other expense, net (25,235) (16,139) (60,668) (54,050)
Income before income tax (benefit) expense 475,237 1,322,739 736,585 5,291,255
Operating Segments        
Segment Reporting Information [Line Items]        
Segment operating income (loss) 4,903,692 5,397,910 13,386,532 16,302,864
Unallocated corporate        
Segment Reporting Information [Line Items]        
Segment operating income (loss) (4,403,220) (4,059,032) (12,589,279) (10,957,559)
Corporate clinics        
Segment Reporting Information [Line Items]        
Revenues 15,836,327 11,634,009 42,936,298 32,537,942
Corporate clinics | Operating Segments        
Segment Reporting Information [Line Items]        
Depreciation and amortization 1,736,757 1,538,251 4,543,253 3,879,786
Segment operating income (loss) (291,866) 1,241,081 (417,313) 4,415,793
Franchise operations        
Segment Reporting Information [Line Items]        
Revenues 10,766,673 9,357,612 31,162,558 26,220,441
Franchise operations | Operating Segments        
Segment Reporting Information [Line Items]        
Depreciation and amortization 189,426 165,475 549,161 166,159
Segment operating income (loss) 5,195,558 4,156,829 13,803,845 11,887,071
Corporate administration        
Segment Reporting Information [Line Items]        
Depreciation and amortization $ 85,585 $ (41,471) $ 249,006 $ 229,195